127 related articles for article (PubMed ID: 35634802)
1. Liquid biopsy in non-small cell lung cancer: Is it ready for prime time yet?
Shrestha DP; Lee DJ; Kao AS
Asia Pac J Clin Oncol; 2023 Apr; 19(2):e3-e4. PubMed ID: 35634802
[No Abstract] [Full Text] [Related]
2. Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non-small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy.
Dal Maso A; Lorenzi M; Roca E; Pilotto S; Macerelli M; Polo V; Cecere FL; Del Conte A; Nardo G; Buoro V; Scattolin D; Monteverdi S; Urso L; Zulato E; Frega S; Bonanno L; Indraccolo S; Calabrese F; Conte P; Pasello G
Clin Lung Cancer; 2020 Jan; 21(1):1-14.e3. PubMed ID: 31601525
[TBL] [Abstract][Full Text] [Related]
3. Cell-Free Circulating Tumour DNA Blood Testing to Detect
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(5):1-176. PubMed ID: 32206157
[TBL] [Abstract][Full Text] [Related]
4. Re-biopsy and liquid biopsy for patients with non-small cell lung cancer after EGFR-tyrosine kinase inhibitor failure.
Zhou J; Zhao C; Zhao J; Wang Q; Chu X; Li J; Zhou F; Ren S; Li X; Su C; Zhou C
Thorac Cancer; 2019 Apr; 10(4):957-965. PubMed ID: 30887673
[TBL] [Abstract][Full Text] [Related]
5. EGFR mutation testing from liquid biopsy of non-small cell lung cancer at the Institute for Oncology and Radiology of Serbia.
Cavic M; Krivokuca A; Pavlovic M; Boljevic I; Rakobradovic J; Mihajlovic M; Tanic M; Damjanovic A; Malisic E; Jankovic R
J BUON; 2020; 25(6):2635-2642. PubMed ID: 33455107
[TBL] [Abstract][Full Text] [Related]
6. Liquid Biopsy Testing for the Management of Patient with Non-Small Cell Lung Cancer Carrying a Rare Exon-20 EGFR Insertion.
Morabito A; Manzo A; Montanino A; Rachiglio AM; Sforza V; Pasquale R; Costanzo R; Maiello MR; Sandomenico C; Gallo M; Palumbo G; De Luca A; La Rocca A; Martucci N; De Cecio R; Picone C; Lastoria S; Normanno N
Oncologist; 2022 Feb; 27(1):7-12. PubMed ID: 35305107
[TBL] [Abstract][Full Text] [Related]
7. Tumor-educated platelet as liquid biopsy in lung cancer patients.
Liu L; Lin F; Ma X; Chen Z; Yu J
Crit Rev Oncol Hematol; 2020 Feb; 146():102863. PubMed ID: 31935617
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Anti-tumor Efficacy of Osimertinib in Non-Small Cell Lung Cancer Patients by Liquid Biopsy Using Bronchoalveolar Lavage Fluid, Plasma, or Pleural Effusion.
Kim YJ; Ji WJ; Lee JC; Chun SM; Choi CM
Cancer Res Treat; 2022 Oct; 54(4):985-995. PubMed ID: 35038824
[TBL] [Abstract][Full Text] [Related]
9. Current Status and Problems of T790M Detection, a Molecular Biomarker of Acquired Resistance to EGFR Tyrosine Kinase Inhibitors, with Liquid Biopsy and Re-biopsy.
Komiya K; Nakashima C; Nakamura T; Hirakawa H; Abe T; Ogusu S; Takahashi K; Takeda Y; Egashira Y; Kimura S; Sueoka-Aragane N
Anticancer Res; 2018 Jun; 38(6):3559-3566. PubMed ID: 29848710
[TBL] [Abstract][Full Text] [Related]
10. EGFR L718V (+)/T790M (-) as a Mechanism of Resistance in Patients with Metastatic Non-small-cell Lung Cancer with EGFR L858R Mutations.
Raez LE; Carracedo C; Drusbosky LM; Velez M; Carlisle J; Stinchcombe T
Clin Lung Cancer; 2021 Nov; 22(6):e817-e819. PubMed ID: 33975777
[No Abstract] [Full Text] [Related]
11. Liquid Biopsy for Disease Monitoring in Non-Small Cell Lung Cancer: The Link between Biology and the Clinic.
Fernandes MGO; Sousa C; Pereira Reis J; Cruz-Martins N; Souto Moura C; Guimarães S; Justino A; Pina MJ; Magalhães A; Queiroga H; Marques JA; Machado JC; Costa JL; Hespanhol V
Cells; 2021 Jul; 10(8):. PubMed ID: 34440680
[TBL] [Abstract][Full Text] [Related]
12. Programmed death-ligand 1 expression in uncommon epidermal growth factor receptor mutation-positive non-small-cell lung cancer.
Taniguchi Y; Takeda M; Tamiya A; Kasai T; Atagi S
Ann Oncol; 2018 Nov; 29(11):2262-2263. PubMed ID: 30202942
[No Abstract] [Full Text] [Related]
13. Miliary EGFR mutated non-small cell lung cancer.
Nguyen MM; Moore MM
Med J Aust; 2021 Feb; 214(3):118. PubMed ID: 33462827
[No Abstract] [Full Text] [Related]
14. Understanding the Mechanisms of Resistance in
Del Re M; Crucitta S; Gianfilippo G; Passaro A; Petrini I; Restante G; Michelucci A; Fogli S; de Marinis F; Porta C; Chella A; Danesi R
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31416192
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of liquid biopsy for EGFR driver, T790M mutation and EGFR amplification in plasma in patients with acquired resistance to afatinib.
Oya Y; Yoshida T; Asada K; Oguri T; Inui N; Morikawa S; Ito K; Kimura T; Kunii E; Matsui T; Kubo A; Kato T; Abe T; Tsuda T; Hida T
BMC Cancer; 2021 Jan; 21(1):57. PubMed ID: 33435905
[TBL] [Abstract][Full Text] [Related]
16. Clinical Features of Patients with an Epidermal Growth Factor Receptor T790M Mutation Detected in Circulating Tumor DNA.
Ikushima H; Sakatani T; Usui K
Oncology; 2020; 98(1):23-28. PubMed ID: 31494653
[TBL] [Abstract][Full Text] [Related]
17. Utility of Liquid Biopsy by Improved PNA-LNA PCR Clamp Method for Detecting EGFR Mutation at Initial Diagnosis of Non-Small-Cell Lung Cancer: Observational Study of 190 Consecutive Cases in Clinical Practice.
Ito K; Suzuki Y; Saiki H; Sakaguchi T; Hayashi K; Nishii Y; Watanabe F; Hataji O
Clin Lung Cancer; 2018 Mar; 19(2):181-190. PubMed ID: 29174086
[TBL] [Abstract][Full Text] [Related]
18. EGFR mutation testing in cytology smears of advanced non-small cell lung carcinomas: Practical applications in low-resource laboratories.
Singh V; Nambirajan A; Malik PS; Kaur K; Mohan A; Jain D
Cytopathology; 2021 Mar; 32(2):287-289. PubMed ID: 33211362
[No Abstract] [Full Text] [Related]
19. [Progress of liquid biopsy technique and clinical application in lung cancer].
Wang NF; Yang Y; Chen SF
Zhonghua Jie He He Hu Xi Za Zhi; 2018 Nov; 41(11):881-883. PubMed ID: 30423633
[No Abstract] [Full Text] [Related]
20. Liquid biopsy for detecting epidermal growth factor receptor mutation among patients with non-small cell lung cancer treated with afatinib: a multicenter prospective study.
Fujii H; Nagakura H; Kobayashi N; Kubo S; Tanaka K; Watanabe K; Horita N; Hara Y; Nishikawa M; Miura K; Koizumi H; Ito Y; Tsubakihara M; Miyazawa N; Kudo M; Shinkai M; Kaneko T
BMC Cancer; 2022 Oct; 22(1):1035. PubMed ID: 36192767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
